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Snake envenomation entails more than 5 million people bitten yearly, out of whom 100,000 died and more than
300,000 are permanently disabled. This prompted the World Health Organization to classify snake envenoming
as a neglected tropical disease in 2017.
In North Africa, we have more than 400.000 cases of envenomation with 50 deaths per year. These numbers
are underestimated with the Cerastes cerastes (Cc) and Macrovipera mauretanica (Mm)are the most medically
important snake species.
To this day, the only medication for snake envenomation is immunotherapy. The lack of a specific antivenom
against Cc and Mm venoms in North Africa, prompted us to develop two monospecific Fab'2 antivenoms in
collaboration with the Butantan Institute in Brazil: one is produced against Moroccan Cc venom and the other
against Moroccan Mm.
While we determiated the paraspecific cross-reactivity of the antivenoms developped, the in vitro paraspecifity
study surprisingly revealed a cross reactivity between the two monospecific Fab'2 antivenoms developped
towards Mm and Cc venoms
venoms from Morocco, Algeria and Tunisia
This convince us to apply an antivenomic approach to assess the immunoreactivity profile of the two antivenoms
towards Cc and Mm venoms from Morocco and Tunisia
our results show that the Tunisian and Moroccan Mm and Cc venoms that are remarkably similar, and for
practical purposes can be regarded as geographic variants. Antivenoms generated in Morocco have a high
degree of paraspecificity.
Then, we can say that The translational venomic approach combining venomic and antivenomic should assist
the preclinical assessment of antivenom efficacy, and will lead to a new generation of pre- and clinically more
effective antivenoms.
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